WHO advisers recommend switch to monovalent COVID vax

WHO advisers recommend switch to monovalent COVID vax

The World Health Organization (WHO) COVID vaccine composition advisory group met to discuss the latest SARS-CoV-2 changes and impacts on the vaccine and recommended that vaccine makers drop the ancestral strain and switch to a monovalent (single-strain) vaccine that...
COVID Drug Candidate Could Reduce Infection Length

COVID Drug Candidate Could Reduce Infection Length

The discovery of a small molecule in the research lab of Bradley McConnell, professor of pharmacology at the University of Houston College of Pharmacy, may well be the genesis of new medication which could shorten the course of the SARS-CoV-2 virus. Unlike Pfizer’s...
Venous blood clots rare among COVID-19 outpatients

Venous blood clots rare among COVID-19 outpatients

An observational study of nearly 400,000 nonhospitalized adults in California finds a low rate of venous thromboembolism (VTE, or a blood clot in a vein) in the 30 days after COVID-19 diagnosis and an even lower rate in the following 30 days. In the University of...
New tool against COVID-19 being put to  test

New tool against COVID-19 being put to test

One of the newly discovered class 6 antibodies (blue) attaching to the SARS-CoV-2 spike protein (green) in a way that causes the spike to break up. CREDIT: Garvan Institute of Medical Research A new class of SARS-CoV-2 antibodies has been shown to neutralize multiple...
Protein-based nanoparticles neutralize SARS-CoV2

Protein-based nanoparticles neutralize SARS-CoV2

Protein-based nanoparticles bind to the SARS-CoV-2 spike protein, preventing infection. The developed nanospheres could have applications in biomedicine. CREDIT: Molood Behbahanipour, Roger Benoit, Susanna Navarro, Salvador Ventura Universitat Autònoma de Barcelona...